JAN 04, 2020 3:08 PM PST

New Protein Therapy Improves Heart Attack Survival Rates

WRITTEN BY: Annie Lennon

Heart disease is the top killer in the Western world. This is partially because, if one manages to survive an initial heart attack, oftentimes the scar tissue it leaves behind increase their chances of developing heart failure later on. Now however, using animal models, researchers have found a way to improve the quality of scar tissue following a heart attack, thus improving health outcomes. 

Currently, approaches taken to reduce scarring after a heart attack focus on restoring blood and oxygen flow to the heart as soon as possible. Although somewhat effective, up to 25% of patients who receive this treatment nevertheless go on to develop heart failure within a year of their first heart attack. Moreover, as many are unable to reach medical care during their attack, with some even not realizing they had one, this treatment is limited in properly preventing harmful scar tissue from forming before it’s too late. 

To combat these problems, researchers from the Westmead Institute for Medical Research and the University of Sydney experimented with a protein therapy known as recombinant human platelet-derived growth factor-AB (rhPDGF-AB). Previously successful in improving heart function in mice following a heart attack, in their new study, they set out to test it on animals more closely related to humans; in this case: pigs. 

After administering an infusion of rhPDGF-AB to pigs post-heart attack, the researchers noted significant improvements in the formation of new blood vessels in the heart, as well as fewer cases of the potentially fatal heart arrhythmia. Although the treatment didn’t affect the overall size of the scar, it nevertheless improved heart function by stimulating an increase in the alignment and strength of scar collagen fiber.

James Chong, leader of the research, said, “This is an entirely new approach with no current treatments able to change scar in this way...By improving cardiac function and scar formation following a heart attack, treatment with rhPDGF-AB led to an overall increase in survival rate in our study."

Having been researched for 10 years so far, Chong and his team hope to further study the treatment option-not just eventtually via human trials, but also on other organ systems impact by scar tissue, such as kidneys. 

 

Sources: New Atlas, ABC News and IFL Science 

 

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
DEC 03, 2019
Cannabis Sciences
DEC 03, 2019
Cannabis Dependence Poses Danger for Post-op Heart Attacks
People undergoing common surgeries are immediately at an increased risk for post-op heart attack and potentially stroke ...
FEB 28, 2020
Cardiology
FEB 28, 2020
Diabetes and Heart Problems Linked to Worse Prognosis of COVID-19
According to most recent data on the COVID-19, the novel coronavirus that emerged in Wuhan, China, those suffering from ...
MAR 12, 2020
Cardiology
MAR 12, 2020
Skipping Breakfast Increases Risk for Heart Disease Death by 87%
According to the old adage, ‘breakfast is the most important meal of the day’. But is that really so? Now, r ...
APR 10, 2020
Cardiology
APR 10, 2020
Drinking Black Tea Reduces Risk of Heart Disease
Black tea is among one of the most commonly consumed beverages around the world. Beyond just being a refreshing and ener ...
APR 18, 2020
Cardiology
APR 18, 2020
Is Good Sleep Necessary for a Healthy Heart?
Over 50 million Americans reportedly have trouble sleeping. As research is increasingly finding that having a good night ...
MAY 25, 2020
Drug Discovery & Development
MAY 25, 2020
Hydrochloroquine Increases Risk of Death by COVID-19
Researchers have found that hydroxychloroquine is not an effective treatment for COVID-19. Their study found that it lea ...
Loading Comments...